Concepedia

Author

Rüdiger E. Port

German Cancer Research Center

Also Known As

R E Port, R. E. Port, R.E. Port, Rudiger E. Port, Rudiger Port, Rüdiger E Port, Rüdiger E. Port, Rüdiger Port

36

Publications

1.3K

Citations

14

H-Index

54

Concepts

All Affiliations

German Cancer Research CenterHeidelberg UniversityDKFZ-ZMBH Alliance
RE

About

Rüdiger E. Port is an author at German Cancer Research Center specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

1.1K

2

Health Sciences

4

4

222

3

Engineering

2

2

791

4

Biochemistry

2

2

176

5

Allergy

1

1

27

Rüdiger E. Port

×

15

Publications

1.2K

Citations

13

H-Index

YearCitations

Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging

Gunnar Brix, Wolfhard Semmler, Rüdiger E. Port,

Journal of Computer Assisted Tomography

1991

660

Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.

William E. Hull, Rüdiger E. Port, Richard Herrmann,

PubMed

1988

131

Quantitative aspects of chemical carcinogenesis and tumor promotion in liver.

Heinz W. Kunz, Henk Tennekes, Rüdiger E. Port,

Environmental Health Perspectives

1983

73

A population model for the leukopenic effect of etoposide*

Mats O. Karlsson, Rüdiger E. Port, Mark J. Ratain,

Clinical Pharmacology & Therapeutics

1995

69

Relative Importance of Dose, Body Surface Area, Sex, and Age for 5-Fluorouracil Clearance

Rüdiger E. Port, Barbel Daniel, Reinhard W. Ding,

Oncology

1991

66

Promoting effect of 4-dimethylaminoazobenzene on enzyme altered foci induced in rat liver by N-nitrosodiethanolamine

Michael Schwarz, Dale Pearson, Rüdiger E. Port,

Carcinogenesis

1984

45

Population Pharmacokinetics of Piritramide in Surgical Patients 

Thomas Bouillon, Daniela Kietzmann, Rüdiger E. Port,

Anesthesiology

1999

34

Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent β- D -glucosylisophosphoramide mustard and its effects on the incorporation of [methyl- 3 H]-thymidine in various tissues of the rat

J Stüben, Rüdiger E. Port, Barbara Bertram,

Cancer Chemotherapy and Pharmacology

1996

27

Kinetic modeling of in vivo—nuclear magnetic resonance spectroscopy data: 5–Fluorouracil in liver and liver tumors

Rüdiger E. Port, Peter Bachert, Wolfhard Semmler

Clinical Pharmacology & Therapeutics

1991

27

Chain‐Fluorinated polyamines as tumour markers. iii. determination of geminal difluoropolyamines and their precursor 2,2‐difluoroputrescine in normal tissues and experimental tumours by <i>in vitro</i> and <i>in vivo</i><sup>19</sup>f NMR spectroscopy

William E. Hull, Werner Kunz, Rüdiger E. Port,

NMR in Biomedicine

1988

20

Page 1